of the effects of toxic chemical substances on mammalian cells is called in vitro toxicology testing. It is employed in identification of hazardous chemicals and to confirm the lack of toxic properties in the early stages of the development new substances. In vitro toxicology testing is considered by key government agencies such as FDA and EPA in order to assess human risks. Rising opposition to animal testing, technological developments and insufficient databases are set to drive the market. The global in vitro toxicology testing market is poised to witness growth of XX% CAGR during the forecast period to reach revenue of $XXm by 2021.
This report provides detailed analysis of the global in vitro toxicology testing market
based on technology such as high throughput, molecular imaging, cell culture and OMICS technologies. The global in vitro toxicology testing market is segmented by end user: cosmetics & household products, food industry, diagnostics, chemicals industry, and pharmaceutical industry. Global in vitro toxicology testing market size is also analyzed based on the geographic regions that include as analysis of Americas, Europe, APAC, and Rest of the World (RoW). The market is further segmented on the basis of the key countries in the region.
Global in vitro toxicology testing market is fragmented market with the presence of significant number of players. Major players in the market includes:
- Agilent Technologies, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Bio Reliance, Inc. (A Subsidiary of Merck & Co, Inc.) (India)
- Catalent Inc. (U.S.)
- Charles River Laboratories International, Inc. (U.S.).
Acquisition and agreement are the key strategies adopted by the key players to enhance their market share. Other major players are:
- Cyprotex (U.K.)
- Covance Inc. (U.S.)
- Charles River Laboratories International, Inc. (U.S.)
- GE Healthcare (U.S.)
- Thermos Fisher Scientific, Inc. (U.S.).